- Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Hsu, S.Y., Hsueh, A.J. Nat. Med. (2001)
- Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes. Chanalaris, A., Lawrence, K.M., Stephanou, A., Knight, R.D., Hsu, S.Y., Hsueh, A.J., Latchman, D.S. J. Mol. Cell. Cardiol. (2003)
- Cross Species Association Examination of UCN3 and CRHR2 as Potential Pharmacological Targets for Antiobesity Drugs. Jiang, Z., Michal, J.J., Williams, G.A., Daniels, T.F., Kunej, T. PLoS ONE (2006)
- Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disorders. Fukuda, T., Takahashi, K., Suzuki, T., Saruta, M., Watanabe, M., Nakata, T., Sasano, H. J. Clin. Endocrinol. Metab. (2005)
- Expression of urocortin 3/stresscopin in human adrenal glands and adrenal tumors. Takahashi, K., Totsune, K., Saruta, M., Fukuda, T., Suzuki, T., Hirose, T., Imai, Y., Sasano, H., Murakami, O. Peptides (2006)
- Spiritual beliefs and barriers among managed care practitioners. McCauley, J., Jenckes, M.W., Tarpley, M.J., Koenig, H.G., Yanek, L.R., Becker, D.M. Journal of religion and health. (2005)
- Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Lewis, K., Li, C., Perrin, M.H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T.M., Gulyas, J., Fischer, W., Bilezikjian, L., Rivier, J., Sawchenko, P.E., Vale, W.W. Proc. Natl. Acad. Sci. U.S.A. (2001)
- cDNA-derived primary structure of the 25-kDa subunit of canine microsomal signal peptidase complex. Greenburg, G., Blobel, G. J. Biol. Chem. (1994)
- Urocortin 3: haemodynamic, hormonal, and renal effects in experimental heart failure. Rademaker, M.T., Cameron, V.A., Charles, C.J., Richards, A.M. Eur. Heart J. (2006)
- Studies of recombinant streptococcal pyrogenic exotoxin B/cysteine protease (rSPE B/SCP) in the skin of guinea pigs & the release of histamine from cultured mast cells & basophilic leukocytes. Ohkuni, H., Todome, Y., Watanabe, Y., Ishikaw, T., Takahashi, H., Kannari, Y., Kato, H., Uchiyama, T., Saito, H., Fischetti, V.A., Zabriskie, J.B. Indian J. Med. Res. (2004)
- Ancient evolution of stress-regulating peptides in vertebrates. Chang, C.L., Hsu, S.Y. Peptides (2004)
- Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells. Aggelidou, E., Hillhouse, E.W., Grammatopoulos, D.K. Proc. Natl. Acad. Sci. U.S.A. (2002)
- Activation of the Nociceptin/Orphanin FQ system is unable to reverse CRF(2) receptor mediated anorexia in the rat. Fedeli, A., Policani, F., Ubaldi, M., Cippitelli, A., Massi, M., Ciccocioppo, R. Peptides (2006)
- Expression of urocortin III/stresscopin in human heart and kidney. Takahashi, K., Totsune, K., Murakami, O., Saruta, M., Nakabayashi, M., Suzuki, T., Sasano, H., Shibahara, S. J. Clin. Endocrinol. Metab. (2004)
- Urocortin 3/stresscopin in human colon: possible modulators of gastrointestinal function during stressful conditions. Saruta, M., Takahashi, K., Suzuki, T., Fukuda, T., Torii, A., Sasano, H. Peptides (2005)
- Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. Li, C., Vaughan, J., Sawchenko, P.E., Vale, W.W. J. Neurosci. (2002)
- Human endometrium expresses urocortin II and III messenger RNA and peptides. Florio, P., Torres, P.B., Torricelli, M., Toti, P., Vale, W., Petraglia, F. Fertil. Steril. (2006)
- Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion. Li, C., Chen, P., Vaughan, J., Blount, A., Chen, A., Jamieson, P.M., Rivier, J., Smith, M.S., Vale, W. Endocrinology (2003)
- Protein kinase C in the treatment of disease: signal transduction pathways, inhibitors, and agents in development. Goekjian, P.G., Jirousek, M.R. Current medicinal chemistry. (1999)
- Cysteine protease activity and histamine release from the human mast cell line HMC-1 stimulated by recombinant streptococcal pyrogenic exotoxin B/streptococcal cysteine protease. Watanabe, Y., Todome, Y., Ohkuni, H., Sakurada, S., Ishikawa, T., Yutsudo, T., Fischetti, V.A., Zabriskie, J.B. Infect. Immun. (2002)
- Endocytic delivery of intramolecularly quenched substrates and inhibitors to the intracellular yeast Kex2 protease1. Henkel, M.K., Pott, G., Henkel, A.W., Juliano, L., Kam, C.M., Powers, J.C., Franzusoff, A. Biochem. J. (1999)
- A prospective randomised controlled trial of intermittent self-catheterisation vs. supra-pubic catheterisation for post-operative bladder care following radical hysterectomy. Naik, R., Maughan, K., Nordin, A., Lopes, A., Godfrey, K.A., Hatem, M.H. Gynecol. Oncol. (2005)